Cargando…
SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor with limited therapeutic options. Glioma stem cell (GSC) is thought to be greatly responsible for glioma tumor progression and drug resistance. But the molecular mechanisms of GSC deriving recurrence and drug resistance are...
Autores principales: | Wang, Zhen, Xu, Xiaoshan, Liu, Nan, Cheng, Yingduan, Jin, Weilin, Zhang, Pengxing, Wang, Xin, Yang, Hongwei, Liu, Hui, Tu, Yanyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787456/ https://www.ncbi.nlm.nih.gov/pubmed/29416606 http://dx.doi.org/10.18632/oncotarget.22773 |
Ejemplares similares
-
Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway
por: Liu, Hui, et al.
Publicado: (2017) -
MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
por: Liu, Nan, et al.
Publicado: (2016) -
Genetic variants of SOX9 contribute to susceptibility of gliomas among Chinese population
por: Wang, Liang, et al.
Publicado: (2016) -
Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma
por: Velpula, Kiran K., et al.
Publicado: (2017) -
TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9
por: Chao, Min, et al.
Publicado: (2021)